abbott glp-1 Launches New PROTALITY™ Brand to Support Adults on Their Weight Loss Journey A New Chapter in FreeStyle

GLP-1 medications such as Ozempic, Wegovy, Mounjaro, and Zepbound have rapidly transformed the management of diabetes and obesity, becoming some of the most requested treatments within employer-sponsored health plans

That's the standard we should be building toward

Liraglutide, a glucagon-like peptide-1 analogue, recently exhibited intriguing potential neuroprotective effects

This report describes use of the GLP-1R agonist semaglutide in a patient with schizophrenia and severe, olanzapine-induced weight gain that was resistant to alternative treatments.

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter 2 inhibitors (SGLT2is) have proven efficacy and safety in randomized clinical trials and observational real-life studies